Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexalin Technology (NXL) Return on Sales (2021 - 2025)

Nexalin Technology has reported Return on Sales over the past 5 years, most recently at 13.83% for Q4 2025.

  • Quarterly results put Return on Sales at 13.83% for Q4 2025, up 9043.0% from a year ago — trailing twelve months through Dec 2025 was 27.25% (up 1786.0% YoY), and the annual figure for FY2025 was 27.25%, up 1786.0%.
  • Return on Sales for Q4 2025 was 13.83% at Nexalin Technology, up from 125.42% in the prior quarter.
  • Over the last five years, Return on Sales for NXL hit a ceiling of 0.56% in Q3 2022 and a floor of 125.42% in Q3 2025.
  • Median Return on Sales over the past 5 years was 24.66% (2021), compared with a mean of 39.09%.
  • Biggest five-year swings in Return on Sales: tumbled -9471bps in 2023 and later skyrocketed 9043bps in 2025.
  • Nexalin Technology's Return on Sales stood at 24.83% in 2021, then rose by 23bps to 19.08% in 2022, then plummeted by -99bps to 38.01% in 2023, then plummeted by -174bps to 104.25% in 2024, then surged by 87bps to 13.83% in 2025.
  • The last three reported values for Return on Sales were 13.83% (Q4 2025), 125.42% (Q3 2025), and 22.4% (Q2 2025) per Business Quant data.